LABCORP HOLDINGS INC.

LH · XNYS

CIK 920148fmd_19S6CFFJX7Y3FBXZQC5729WPN9Services · Services-Medical LaboratoriesTemplate: Standard

Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	9,553	10,308	11,333	11,555	13,979	13,136	11,864	12,162	13,009	13,952
Cost of revenue	6,699	7,216	8,157	8,302	9,026	8,144	8,155	8,797	9,385	9,939
Gross profit	2,854	3,092	3,176	3,253	4,953	4,992	3,709	3,365	3,624	4,013
Selling, general and administrative	1,346	1,499	1,571	1,625	1,729	1,690	1,763	2,021	2,230	2,216
Operating income	1,271	1,305	1,326	1,330	2,445	3,049	1,437	726	1,087	1,385
Interest expense	219	235	244	241	207	212	180	200	208	224
Other non-operating income (expense)	(197)	(228)	(57)	(225)	(226)	16	(32)	16	60	(55)
Income before taxes	1,074	1,078	1,268	1,105	2,219	2,888	1,237	569	960	1,108
Income tax expense	361	(155)	384	280	662	690	234	189	212	230
Net income from continuing operations	713	1,233	884	825	1,557	2,198	1,004	380	747	878
Net income	712	1,227	884	824	1,556	2,377	1,279	418	746	877
Net income to common shareholders	712	1,227	884	824	1,556	2,377	1,279	418	746	877